http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108324718-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108324718-B
titleOfInvention Application of cyclohexyl methoxy formyl amino chloro benzo aza group quinazoline compound in leukemia treatment drug
abstract The invention discloses cyclohexyl methoxy formyl amino chloro benzo aza The application of the quinazoline compound in preparing medicaments for preventing or treating tumors, in particular in preparing medicaments for preventing or treating human leukemia has a remarkable effect on inhibiting the activity of a human promyelocytic leukemia cell line HL-60.
priorityDate 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448578480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21891449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11356257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20197112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447846986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69738355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410508661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421108753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450418934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453534338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415770253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID600211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413586446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426176796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415757211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416033200

Total number of triples: 51.